Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05651243 · ClinicalTrials.gov registry record · NA
Ketone Esters for Appetite, Cognition, and Cardiovascular Function in Individuals With Obesity and Insulin Resistance
A NA study, sponsored by University of Southern Mississippi.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05651243 is a NA study that has completed, run by University of Southern Mississippi. The registered enrollment target is 20 participants.
The verdict
NCT05651243, a NA study, has completed, sponsored by University of Southern Mississippi.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this single-blind randomized placebo-controlled trial is to test the effects of an oral ketone supplement on appetite, cognition, metabolism, and cardiovascular function in individuals with obesity and insulin resistance. The main question\[s\] it aims to answer are: * Does taking the ketone supplement reduce appetite and improve cognition? * How does the ketone supplement alter metabolism and cardiovascular function? Participants will be asked to consume a randomly assigned ketone ester supplement or a placebo and testing will be done to see how the supplement affects the following compared to a placebo: * appetite, * cognition, * metabolism * cardiovascular function Researchers will compare individuals with obesity and insulin resistance to individuals with normal weight and no insulin resistance to see if the ketone supplement affects groups differently.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ketone Ester Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-12-28 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05651243
The ClinicalTrials.gov registry entry for NCT05651243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern Mississippi, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05651243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05651243 about?
NCT05651243 is a clinical study titled "Ketone Esters for Appetite, Cognition, and Cardiovascular Function in Individuals With Obesity and Insulin Resistance". The goal of this single-blind randomized placebo-controlled trial is to test the effects of an oral ketone supplement on appetite, cognition, metabolism, and cardiovascular function in individuals with obesity and insulin resistance. The main question\[s\] it aims to answer are: * Does taking the ...
What is the current status of trial NCT05651243?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-12-28. Estimated completion is 2023-12-29.
What interventions are being tested in trial NCT05651243?
The interventions under investigation include: Placebo (OTHER), Ketone Ester Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05651243?
This trial is sponsored by University of Southern Mississippi, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.